首页 > 最新文献

Indian Journal of Critical Care Medicine最新文献

英文 中文
Hydrocortisone for Septic Shock, Bolus or Infusion: Pro, Con, May be. 氢化可的松治疗脓毒性休克,注射还是输注?赞成、反对、可能
IF 1.5 Q3 CRITICAL CARE MEDICINE Pub Date : 2024-09-01 Epub Date: 2024-08-31 DOI: 10.5005/jp-journals-10071-24798
Subhash Todi

How to cite this article: Todi S. Hydrocortisone for Septic Shock, Bolus or Infusion: Pro, Con, May be. Indian J Crit Care Med 2024;28(9):816-817.

如何引用本文:Todi S. 氢化可的松治疗脓毒性休克,静脉注射还是静脉输注:赞成、反对、可能。Indian J Crit Care Med 2024;28(9):816-817.
{"title":"Hydrocortisone for Septic Shock, Bolus or Infusion: Pro, Con, May be.","authors":"Subhash Todi","doi":"10.5005/jp-journals-10071-24798","DOIUrl":"10.5005/jp-journals-10071-24798","url":null,"abstract":"<p><p><b>How to cite this article:</b> Todi S. Hydrocortisone for Septic Shock, Bolus or Infusion: Pro, Con, May be. Indian J Crit Care Med 2024;28(9):816-817.</p>","PeriodicalId":47664,"journal":{"name":"Indian Journal of Critical Care Medicine","volume":"28 9","pages":"816-817"},"PeriodicalIF":1.5,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11443267/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142368198","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Author Response: Nocturnal Infusion of Low-dose Dexmedetomidine and Propofol for Delirium Prevention. 作者回复:夜间输注低剂量右美托咪定和丙泊酚预防谵妄。
IF 1.5 Q3 CRITICAL CARE MEDICINE Pub Date : 2024-09-01 Epub Date: 2024-08-31 DOI: 10.5005/jp-journals-10071-24791
Gamonmas Ekkapat, Nalin Chokengarmwong

How to cite this article: Ekkapat G, Chokengarmwong N. Author Response: Nocturnal Infusion of Low-dose Dexmedetomidine and Propofol for Delirium Prevention. Indian J Crit Care Med 2024;28(9):896.

如何引用本文:Ekkapat G, Chokengarmwong N. Author Response:夜间输注低剂量右美托咪定和丙泊酚预防谵妄。Indian J Crit Care Med 2024;28(9):896.
{"title":"Author Response: Nocturnal Infusion of Low-dose Dexmedetomidine and Propofol for Delirium Prevention.","authors":"Gamonmas Ekkapat, Nalin Chokengarmwong","doi":"10.5005/jp-journals-10071-24791","DOIUrl":"10.5005/jp-journals-10071-24791","url":null,"abstract":"<p><p><b>How to cite this article:</b> Ekkapat G, Chokengarmwong N. Author Response: Nocturnal Infusion of Low-dose Dexmedetomidine and Propofol for Delirium Prevention. Indian J Crit Care Med 2024;28(9):896.</p>","PeriodicalId":47664,"journal":{"name":"Indian Journal of Critical Care Medicine","volume":"28 9","pages":"896"},"PeriodicalIF":1.5,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11443260/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142366973","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nocturnal Infusion of Low-dose Dexmedetomidine and Propofol for Prevention of Delirium Occurring in the ICU after Hip Fracture Surgery in Elderly Patients. 夜间输注低剂量右美托咪定和丙泊酚预防老年髋部骨折手术后在重症监护室出现谵妄。
IF 1.5 Q3 CRITICAL CARE MEDICINE Pub Date : 2024-09-01 Epub Date: 2024-08-31 DOI: 10.5005/jp-journals-10071-24780
Ning Cong, Dan-Feng Wang, Fu-Shan Xue

How to cite this article: Cong N, Wang D, Xue F. Nocturnal Infusion of Low-dose Dexmedetomidine and Propofol for Prevention of Delirium Occurring in the ICU after Hip Fracture Surgery in Elderly Patients. Indian J Crit Care Med 2024;28(9):894-895.

本文引用方式Cong N, Wang D, Xue F. 低剂量右美托咪定和丙泊酚夜间输注预防老年髋部骨折术后ICU谵妄的研究.Indian J Crit Care Med 2024;28(9):894-895.
{"title":"Nocturnal Infusion of Low-dose Dexmedetomidine and Propofol for Prevention of Delirium Occurring in the ICU after Hip Fracture Surgery in Elderly Patients.","authors":"Ning Cong, Dan-Feng Wang, Fu-Shan Xue","doi":"10.5005/jp-journals-10071-24780","DOIUrl":"10.5005/jp-journals-10071-24780","url":null,"abstract":"<p><p><b>How to cite this article:</b> Cong N, Wang D, Xue F. Nocturnal Infusion of Low-dose Dexmedetomidine and Propofol for Prevention of Delirium Occurring in the ICU after Hip Fracture Surgery in Elderly Patients. Indian J Crit Care Med 2024;28(9):894-895.</p>","PeriodicalId":47664,"journal":{"name":"Indian Journal of Critical Care Medicine","volume":"28 9","pages":"894-895"},"PeriodicalIF":1.5,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11443277/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142366979","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predicting Secondary Hemophagocytic Lymphohistiocytosis in Adult Patients with Scrub Typhus and Its Prognostic Significance. 恙虫病成人患者继发性嗜血细胞淋巴组织细胞增多症的预测及其预后意义
IF 1.5 Q3 CRITICAL CARE MEDICINE Pub Date : 2024-09-01 Epub Date: 2024-08-31 DOI: 10.5005/jp-journals-10071-24787
Suresh Selvam, Akshit Tuli, Kumar P Yuvasai, Shashikant Saini, Sathvik R Erla, Jyotdeep Kaur, Manisha Biswal, Navneet Sharma, Ashok K Pannu

Objective: Secondary hemophagocytic lymphohistiocytosis (sHLH) is an increasingly recognized complication in patients with scrub typhus, potentially contributing to substantial mortality despite appropriate antibiotic treatment. This study aims to determine the prevalence and prognosis of sHLH and identify diagnostic factors in adult patients with scrub typhus in North India.

Methods: This prospective cohort study was conducted at PGIMER, Chandigarh, from August 2021 to November 2023. sHLH was defined as an HScore of 200 or above. The diagnostic performance of biomarkers such as ferritin, fibrinogen, triglycerides, and C-reactive protein was assessed through receiver operating characteristic curve analysis, evaluating area under the curve (AUC), sensitivity, and specificity.

Results: Out of 150 patients (mean age 39 years, 54% female), 28 (18.7%) were diagnosed with sHLH. Those presenting with high-grade fever, seizures, high pulse rate, hepatomegaly, splenomegaly, cytopenia, and significant hepatic dysfunction were more likely to have sHLH. Ferritin demonstrated the highest diagnostic utility (AUC 0.83), compared to fibrinogen (AUC 0.72), triglyceride (AUC 0.67), and C-reactive protein (AUC 0.69). The optimal cutoff for ferritin was 2000 ng/mL, with a sensitivity of 90% and a specificity of 66%. Higher ferritin thresholds (6000 ng/mL and 10000 ng/mL) increased specificity to 88% and 95%, respectively. Patients with sHLH often presented with multi-organ failure, necessitating mechanical ventilation and vasopressor support. In-hospital mortality was significantly higher in sHLH patients than in those without (21.4% vs 6.6%, p = 0.025).

Conclusion: Early detection of sHLH using the HScore and ferritin significantly influences the management of scrub typhus, underscoring the necessity for tailored therapeutic strategies to improve patient outcomes.

How to cite this article: Selvam S, Tuli A, Yuvasai KP, Saini S, Erla SR, Kaur J, et al. Predicting Secondary Hemophagocytic Lymphohistiocytosis in Adult Patients with Scrub Typhus and Its Prognostic Significance. Indian J Crit Care Med 2024;28(9):823-831.

目的:继发性嗜血细胞淋巴组织细胞增多症(sHLH继发性嗜血细胞淋巴组织细胞增多症(sHLH)是恙虫病患者中一种日益被认可的并发症,尽管经过适当的抗生素治疗,但仍有可能导致大量死亡。本研究旨在确定sHLH的发病率和预后,并确定北印度恙虫病成年患者的诊断因素:这项前瞻性队列研究于 2021 年 8 月至 2023 年 11 月在昌迪加尔的 PGIMER 进行。通过接收器工作特征曲线分析评估了铁蛋白、纤维蛋白原、甘油三酯和 C 反应蛋白等生物标志物的诊断性能,评价了曲线下面积(AUC)、灵敏度和特异性:在 150 名患者(平均年龄 39 岁,54% 为女性)中,28 人(18.7%)被确诊为 sHLH。伴有高热、癫痫发作、高脉搏率、肝肿大、脾肿大、全血细胞减少和明显肝功能异常的患者更有可能患有 sHLH。与纤维蛋白原(AUC 0.72)、甘油三酯(AUC 0.67)和 C 反应蛋白(AUC 0.69)相比,铁蛋白的诊断效用最高(AUC 0.83)。铁蛋白的最佳临界值为 2000 纳克/毫升,灵敏度为 90%,特异性为 66%。更高的铁蛋白临界值(6000 纳克/毫升和 10000 纳克/毫升)可将特异性分别提高到 88% 和 95%。sHLH患者通常会出现多器官功能衰竭,需要机械通气和血管加压支持。sHLH患者的院内死亡率明显高于非sHLH患者(21.4% vs 6.6%,P = 0.025):结论:使用HScore和铁蛋白及早检测出sHLH对恙虫病的治疗有重大影响,强调有必要制定有针对性的治疗策略以改善患者预后:Selvam S, Tuli A, Yuvasai KP, Saini S, Erla SR, Kaur J, et al.Indian J Crit Care Med 2024;28(9):823-831.
{"title":"Predicting Secondary Hemophagocytic Lymphohistiocytosis in Adult Patients with Scrub Typhus and Its Prognostic Significance.","authors":"Suresh Selvam, Akshit Tuli, Kumar P Yuvasai, Shashikant Saini, Sathvik R Erla, Jyotdeep Kaur, Manisha Biswal, Navneet Sharma, Ashok K Pannu","doi":"10.5005/jp-journals-10071-24787","DOIUrl":"10.5005/jp-journals-10071-24787","url":null,"abstract":"<p><strong>Objective: </strong>Secondary hemophagocytic lymphohistiocytosis (sHLH) is an increasingly recognized complication in patients with scrub typhus, potentially contributing to substantial mortality despite appropriate antibiotic treatment. This study aims to determine the prevalence and prognosis of sHLH and identify diagnostic factors in adult patients with scrub typhus in North India.</p><p><strong>Methods: </strong>This prospective cohort study was conducted at PGIMER, Chandigarh, from August 2021 to November 2023. sHLH was defined as an HScore of 200 or above. The diagnostic performance of biomarkers such as ferritin, fibrinogen, triglycerides, and C-reactive protein was assessed through receiver operating characteristic curve analysis, evaluating area under the curve (AUC), sensitivity, and specificity.</p><p><strong>Results: </strong>Out of 150 patients (mean age 39 years, 54% female), 28 (18.7%) were diagnosed with sHLH. Those presenting with high-grade fever, seizures, high pulse rate, hepatomegaly, splenomegaly, cytopenia, and significant hepatic dysfunction were more likely to have sHLH. Ferritin demonstrated the highest diagnostic utility (AUC 0.83), compared to fibrinogen (AUC 0.72), triglyceride (AUC 0.67), and C-reactive protein (AUC 0.69). The optimal cutoff for ferritin was 2000 ng/mL, with a sensitivity of 90% and a specificity of 66%. Higher ferritin thresholds (6000 ng/mL and 10000 ng/mL) increased specificity to 88% and 95%, respectively. Patients with sHLH often presented with multi-organ failure, necessitating mechanical ventilation and vasopressor support. In-hospital mortality was significantly higher in sHLH patients than in those without (21.4% vs 6.6%, <i>p</i> = 0.025).</p><p><strong>Conclusion: </strong>Early detection of sHLH using the HScore and ferritin significantly influences the management of scrub typhus, underscoring the necessity for tailored therapeutic strategies to improve patient outcomes.</p><p><strong>How to cite this article: </strong>Selvam S, Tuli A, Yuvasai KP, Saini S, Erla SR, Kaur J, <i>et al</i>. Predicting Secondary Hemophagocytic Lymphohistiocytosis in Adult Patients with Scrub Typhus and Its Prognostic Significance. Indian J Crit Care Med 2024;28(9):823-831.</p>","PeriodicalId":47664,"journal":{"name":"Indian Journal of Critical Care Medicine","volume":"28 9","pages":"823-831"},"PeriodicalIF":1.5,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11443264/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142366983","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Protocolized Regional Citrate Anticoagulation during Continuous Renal Replacement Therapy: A Single Center Experience. 持续肾脏替代疗法期间的区域性枸橼酸盐抗凝治疗方案:单中心经验
IF 1.5 Q3 CRITICAL CARE MEDICINE Pub Date : 2024-09-01 Epub Date: 2024-08-31 DOI: 10.5005/jp-journals-10071-24797
Anant V Pachisia, G Praveen Kumar, Rahul Harne, K N Jagadeesh, Sweta J Patel, Divya Pal, Pooja Tyagi, Swagat Pattajoshi, Keerti Brar, Parimal B Patel, Ronak Zatakiya, Subhash Chandra, Deepak Govil

Background: Regional citrate anticoagulation (RCA) has emerged as a treatment modality that reduces bleeding risk and filter clotting. With initial experience of using RCA with continuous renal replacement therapy (CRRT), we have formulated a working protocol based on published literature.

Objective: The study aimed to evaluate the protocol for routine use of RCA during CRRT requiring anticoagulation and evaluation of filter life.

Methodology: It is a single-center, open-label, prospective, non-randomized, non-interventional, single-arm, observational study conducted at a tertiary care hospital between September 2022 and July 2023. All adult patients with acute kidney injury (AKI) or hyperammonemia requiring CRRT and necessitating the use of anticoagulation were enrolled in the study. The study used Prisma Flex M100 AN 69 dialyzer on Prisma Flex (Baxter) CRRT machines during continuous venovenous hemodiafiltration (CVVHDF). The targeted CRRT dose in all the study patients was 25-30 mL/kg/hour. Based on the published literature, we have developed a working protocol (Appendix 1) for managing patients on CRRT using RCA.

Results: A total of 159 patients were analyzed for the study. The median [interquartile range (IQR)] filter life using RCA was 30 (12-55) hours. Filter clotting was observed in 33.3% of patients. Citrate accumulation was present in 52.25% of patients, but no CRRT was discontinued as citrate accumulation resolved after following the corrective steps in the protocol. None of the patients had citrate toxicity. Chronic liver disease (CLD) (p ≤ 0.001) and those who were post-living donor liver transplant recipients (p = 0.004) had a statistically significant increase in citrate accumulation. Also, patients who had higher lactate at baseline (6 hours post-CRRT initiation), had a higher chance of citrate accumulation.

Conclusion: Our RCA protocol provides a safe approach to regional anticoagulation during CRRT in critically ill patients.

How to cite this article: Pachisia AV, Kumar GP, Harne R, Jagadeesh KN, Patel SJ, Pal D, et al. Protocolized Regional Citrate Anticoagulation during Continuous Renal Replacement Therapy: A Single Center Experience. Indian J Crit Care Med 2024;28(9):859-865.

背景:区域性枸橼酸盐抗凝(RCA)已成为一种可降低出血风险和过滤凝血的治疗方式。根据在持续肾脏替代治疗(CRRT)中使用 RCA 的初步经验,我们根据已发表的文献制定了一套工作方案:该研究旨在评估在需要抗凝的 CRRT 期间常规使用 RCA 的方案,并评估过滤器的使用寿命:这是一项单中心、开放标签、前瞻性、非随机、非干预、单臂、观察性研究,于2022年9月至2023年7月在一家三级医院进行。所有患有急性肾损伤(AKI)或高氨血症、需要进行 CRRT 且必须使用抗凝药物的成年患者均被纳入研究。研究使用 Prisma Flex (Baxter) CRRT 机上的 Prisma Flex M100 AN 69 透析器进行连续静脉血液透析(CVVHDF)。所有研究患者的 CRRT 目标剂量均为 25-30 毫升/千克/小时。根据已发表的文献,我们制定了使用 RCA 管理 CRRT 患者的工作方案(附录 1):本研究共分析了 159 名患者。使用 RCA 的过滤器寿命中位数[四分位数间距 (IQR)]为 30 (12-55) 小时。33.3%的患者观察到过滤器凝结。52.25%的患者出现了枸橼酸盐蓄积,但由于枸橼酸盐蓄积在按照方案采取纠正措施后得到缓解,因此没有患者停止 CRRT。没有一名患者出现枸橼酸盐中毒。慢性肝病(CLD)(p ≤ 0.001)和接受活体肝移植后的患者(p = 0.004)的枸橼酸盐蓄积有显著的统计学意义。此外,基线(CRRT 开始后 6 小时)乳酸较高的患者出现枸橼酸盐蓄积的几率也较高:我们的 RCA 方案为重症患者在 CRRT 期间进行区域抗凝提供了一种安全的方法:Pachisia AV, Kumar GP, Harne R, Jagadeesh KN, Patel SJ, Pal D, et al:单中心经验。Indian J Crit Care Med 2024;28(9):859-865.
{"title":"Protocolized Regional Citrate Anticoagulation during Continuous Renal Replacement Therapy: A Single Center Experience.","authors":"Anant V Pachisia, G Praveen Kumar, Rahul Harne, K N Jagadeesh, Sweta J Patel, Divya Pal, Pooja Tyagi, Swagat Pattajoshi, Keerti Brar, Parimal B Patel, Ronak Zatakiya, Subhash Chandra, Deepak Govil","doi":"10.5005/jp-journals-10071-24797","DOIUrl":"10.5005/jp-journals-10071-24797","url":null,"abstract":"<p><strong>Background: </strong>Regional citrate anticoagulation (RCA) has emerged as a treatment modality that reduces bleeding risk and filter clotting. With initial experience of using RCA with continuous renal replacement therapy (CRRT), we have formulated a working protocol based on published literature.</p><p><strong>Objective: </strong>The study aimed to evaluate the protocol for routine use of RCA during CRRT requiring anticoagulation and evaluation of filter life.</p><p><strong>Methodology: </strong>It is a single-center, open-label, prospective, non-randomized, non-interventional, single-arm, observational study conducted at a tertiary care hospital between September 2022 and July 2023. All adult patients with acute kidney injury (AKI) or hyperammonemia requiring CRRT and necessitating the use of anticoagulation were enrolled in the study. The study used Prisma Flex M100 AN 69 dialyzer on Prisma Flex (Baxter) CRRT machines during continuous venovenous hemodiafiltration (CVVHDF). The targeted CRRT dose in all the study patients was 25-30 mL/kg/hour. Based on the published literature, we have developed a working protocol (Appendix 1) for managing patients on CRRT using RCA.</p><p><strong>Results: </strong>A total of 159 patients were analyzed for the study. The median [interquartile range (IQR)] filter life using RCA was 30 (12-55) hours. Filter clotting was observed in 33.3% of patients. Citrate accumulation was present in 52.25% of patients, but no CRRT was discontinued as citrate accumulation resolved after following the corrective steps in the protocol. None of the patients had citrate toxicity. Chronic liver disease (CLD) (<i>p</i> ≤ 0.001) and those who were post-living donor liver transplant recipients (<i>p</i> = 0.004) had a statistically significant increase in citrate accumulation. Also, patients who had higher lactate at baseline (6 hours post-CRRT initiation), had a higher chance of citrate accumulation.</p><p><strong>Conclusion: </strong>Our RCA protocol provides a safe approach to regional anticoagulation during CRRT in critically ill patients.</p><p><strong>How to cite this article: </strong>Pachisia AV, Kumar GP, Harne R, Jagadeesh KN, Patel SJ, Pal D, <i>et al</i>. Protocolized Regional Citrate Anticoagulation during Continuous Renal Replacement Therapy: A Single Center Experience. Indian J Crit Care Med 2024;28(9):859-865.</p>","PeriodicalId":47664,"journal":{"name":"Indian Journal of Critical Care Medicine","volume":"28 9","pages":"859-865"},"PeriodicalIF":1.5,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11443258/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142366992","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Left Ventricular Diastolic Dysfunction in the Critically Ill: The Rubik's Cube of Echocardiography. 重症患者的左心室舒张功能障碍:超声心动图的魔方。
IF 1.5 Q3 CRITICAL CARE MEDICINE Pub Date : 2024-09-01 Epub Date: 2024-08-31 DOI: 10.5005/jp-journals-10071-24801
Vivek Kumar

How to cite this article: Kumar V. Left Ventricular Diastolic Dysfunction in the Critically Ill: The Rubik's Cube of Echocardiography. Indian J Crit Care Med 2024;28(9):813-815.

如何引用本文:Kumar V. 重症患者的左心室舒张功能障碍:超声心动图的魔方。Indian J Crit Care Med 2024;28(9):813-815.
{"title":"Left Ventricular Diastolic Dysfunction in the Critically Ill: The Rubik's Cube of Echocardiography.","authors":"Vivek Kumar","doi":"10.5005/jp-journals-10071-24801","DOIUrl":"10.5005/jp-journals-10071-24801","url":null,"abstract":"<p><p><b>How to cite this article:</b> Kumar V. Left Ventricular Diastolic Dysfunction in the Critically Ill: The Rubik's Cube of Echocardiography. Indian J Crit Care Med 2024;28(9):813-815.</p>","PeriodicalId":47664,"journal":{"name":"Indian Journal of Critical Care Medicine","volume":"28 9","pages":"813-815"},"PeriodicalIF":1.5,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11443268/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142368199","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
"Financially Palliative": The Need to Address a Perplexing Financial Conundrum in Emergency and Critical Care. "财政上的姑息":需要解决急诊和重症监护中令人困惑的财务难题。
IF 1.5 Q3 CRITICAL CARE MEDICINE Pub Date : 2024-09-01 Epub Date: 2024-08-31 DOI: 10.5005/jp-journals-10071-24786
Rachana Bhat, Akshaya Ramaswami

The terminology "Financially Palliative" is a pseudonym and refers to a unique challenge faced in countries where public healthcare insurance coverage is not robust and the percentage of out-of-pocket health expenditure continues to be high. Emergency and critical care healthcare expenditures in such circumstances usually pose additional burden as they are unforeseen expenses, disproportionately high, for which most people are unprepared. Such situations may lead into a vicious cycle that initiates with expenditure hesitancy and delay in definitive care, which in turn leads to deterioration in the patient's condition and delay-related complications. This further fuels expenditure hesitancy due to uncertain prognosis and outcomes. The future threats posed by this issue are manifold, which are not only restricted to poor patient outcomes and diminishing physician morale but also hinder progress in science by influencing research outcomes/endpoints in areas where it is highly prevalent. Identifying and defining the problem with terminology is only the first step in working towards solutions. The issue needs to be addressed and mitigated before it spreads its roots deeper into our healthcare system.

How to cite this article: Bhat R, Ramaswami A. "Financially Palliative": The Need to Address a Perplexing Financial Conundrum in Emergency and Critical Care. Indian J Crit Care Med 2024;28(9):820-822.

财政姑息 "是一个化名,指的是在公共医疗保险覆盖率不高、自付医疗费用比例持续较高的国家所面临的独特挑战。在这种情况下,急诊和危重病人的医疗支出通常会造成额外负担,因为这些支出是不可预见的,而且不成比例地高,大多数人对此毫无准备。这种情况可能会导致恶性循环,首先是支出犹豫不决,延误最终治疗,进而导致病人病情恶化和与延误有关的并发症。由于预后和结果不确定,这进一步加剧了支出犹豫。这一问题对未来造成的威胁是多方面的,不仅限于患者的不良预后和医生士气的低落,还通过影响高发领域的研究成果/终点而阻碍科学进步。发现和界定术语问题只是努力解决问题的第一步。我们需要在这个问题深入医疗系统之前加以解决和缓解:Bhat R, Ramaswami A. "Financially Palliative":解决急诊和重症监护中令人困惑的财务难题的必要性。Indian J Crit Care Med 2024;28(9):820-822.
{"title":"\"Financially Palliative\": The Need to Address a Perplexing Financial Conundrum in Emergency and Critical Care.","authors":"Rachana Bhat, Akshaya Ramaswami","doi":"10.5005/jp-journals-10071-24786","DOIUrl":"10.5005/jp-journals-10071-24786","url":null,"abstract":"<p><p>The terminology \"Financially Palliative\" is a pseudonym and refers to a unique challenge faced in countries where public healthcare insurance coverage is not robust and the percentage of out-of-pocket health expenditure continues to be high. Emergency and critical care healthcare expenditures in such circumstances usually pose additional burden as they are unforeseen expenses, disproportionately high, for which most people are unprepared. Such situations may lead into a vicious cycle that initiates with expenditure hesitancy and delay in definitive care, which in turn leads to deterioration in the patient's condition and delay-related complications. This further fuels expenditure hesitancy due to uncertain prognosis and outcomes. The future threats posed by this issue are manifold, which are not only restricted to poor patient outcomes and diminishing physician morale but also hinder progress in science by influencing research outcomes/endpoints in areas where it is highly prevalent. Identifying and defining the problem with terminology is only the first step in working towards solutions. The issue needs to be addressed and mitigated before it spreads its roots deeper into our healthcare system.</p><p><strong>How to cite this article: </strong>Bhat R, Ramaswami A. \"Financially Palliative\": The Need to Address a Perplexing Financial Conundrum in Emergency and Critical Care. Indian J Crit Care Med 2024;28(9):820-822.</p>","PeriodicalId":47664,"journal":{"name":"Indian Journal of Critical Care Medicine","volume":"28 9","pages":"820-822"},"PeriodicalIF":1.5,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11443273/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142366971","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pediatric Sepsis - Sailing the Unchartered Waters with Omics. 小儿败血症--利用 Omics 技术在未知水域航行。
IF 1.5 Q3 CRITICAL CARE MEDICINE Pub Date : 2024-09-01 Epub Date: 2024-08-31 DOI: 10.5005/jp-journals-10071-24799
Mullai Baalaaji

How to cite this article: Baalaaji M. Pediatric Sepsis - Sailing the Unchartered Waters with Omics. Indian J Crit Care Med 2024;28(9):818-819.

如何引用本文:Baalaaji M. Pediatric Sepsis - Sailing the Unchartered Waters with Omics.Indian J Crit Care Med 2024;28(9):818-819.
{"title":"Pediatric Sepsis - Sailing the Unchartered Waters with Omics.","authors":"Mullai Baalaaji","doi":"10.5005/jp-journals-10071-24799","DOIUrl":"10.5005/jp-journals-10071-24799","url":null,"abstract":"<p><p><b>How to cite this article:</b> Baalaaji M. Pediatric Sepsis - Sailing the Unchartered Waters with Omics. Indian J Crit Care Med 2024;28(9):818-819.</p>","PeriodicalId":47664,"journal":{"name":"Indian Journal of Critical Care Medicine","volume":"28 9","pages":"818-819"},"PeriodicalIF":1.5,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11443276/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142366982","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Author Response: Oxygenation Indices in Adult COVID ARDS Patients. 作者回复:成人 COVID ARDS 患者的氧合指数。
IF 1.5 Q3 CRITICAL CARE MEDICINE Pub Date : 2024-09-01 Epub Date: 2024-08-31 DOI: 10.5005/jp-journals-10071-24790
Sonali Mr Vadi, Neha Sanwalka, Durga Suthar

How to cite this article: Vadi SMR, Sanwalka N, Suthar D. Author Response: Oxygenation Indices in Adult COVID ARDS Patients. Indian J Crit Care Med 2024;28(9):889.

本文引用方式Vadi SMR, Sanwalka N, Suthar D. Author Response:成人 COVID ARDS 患者的氧合指数。Indian J Crit Care Med 2024;28(9):889.
{"title":"Author Response: Oxygenation Indices in Adult COVID ARDS Patients.","authors":"Sonali Mr Vadi, Neha Sanwalka, Durga Suthar","doi":"10.5005/jp-journals-10071-24790","DOIUrl":"10.5005/jp-journals-10071-24790","url":null,"abstract":"<p><p><b>How to cite this article:</b> Vadi SMR, Sanwalka N, Suthar D. Author Response: Oxygenation Indices in Adult COVID ARDS Patients. Indian J Crit Care Med 2024;28(9):889.</p>","PeriodicalId":47664,"journal":{"name":"Indian Journal of Critical Care Medicine","volume":"28 9","pages":"889"},"PeriodicalIF":1.5,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11443261/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142366975","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence and Outcomes of Carbamazepine Toxicity in the Emergency Department: A Single-center Retrospective Study. 急诊科中卡马西平中毒的发生率和结果:单中心回顾性研究
IF 1.5 Q3 CRITICAL CARE MEDICINE Pub Date : 2024-09-01 Epub Date: 2024-08-31 DOI: 10.5005/jp-journals-10071-24795
Darpanarayan Hazra, Nejah F Ellouze, Suad A Abri

Background: Carbamazepine (CBX) is widely used for various medical conditions, but its associated toxicity poses significant clinical concerns. This study aims to provide insights into the clinical presentations, management strategies, and outcomes of CBX toxicity cases in an emergency department (ED) setting.

Methodology: This was a 10-year retrospective cohort chart review study, including all patients with elevated CBX levels. Data on clinical features, CBX levels, laboratory findings, electrocardiograms (ECGs), patient management, and outcomes were analyzed. Cases were categorized as acute or chronic toxicity.

Results: Out of the 1,965 medical charts reviewed, we included 70 patients with CBX levels above the therapeutic range (prevalence: 3.6%). Chronic CBX toxicity cases (55.7%) were predominant, with gastrointestinal (GI) symptoms being the most common. Most patients presented with isolated CBX overdoses (88.6%), while mixed overdoses (11.4%) were less frequent. Patients were categorized based on CBX levels: 44 had mild toxicity (>51 μmol/L), and 26 had moderate toxicity (>85 μmol/L). Within the mild group, 15 patients experienced acute toxicity, compared to 16 patients in the moderate group. Four patients who had mixed overdoses and low sensorium required intubation and mechanical ventilation. Three patients received activated charcoal (AC), and another 3 patients received multiple doses of AC to reduce drug absorption. The majority of patients (65.7%) required hospital admission, underscoring the seriousness of CBX toxicity. There were no fatalities among these 70 patients.

Conclusion: This study emphasizes the importance of a systematic approach to assessing and managing CBX toxicity, considering its diverse clinical presentations and variations in serum CBX levels.

How to cite this article: Hazra D, Ellouze NF, Abri SA. Prevalence and Outcomes of Carbamazepine Toxicity in the Emergency Department: A Single-center Retrospective Study. Indian J Crit Care Med 2024;28(9):866-870.

背景:卡马西平(CBX卡马西平(CBX)被广泛用于治疗各种内科疾病,但其相关毒性引起了严重的临床问题。本研究旨在深入了解急诊科(ED)中卡马西平毒性病例的临床表现、管理策略和治疗效果:这是一项为期 10 年的回顾性队列病历审查研究,包括所有 CBX 水平升高的患者。研究分析了临床特征、CBX 水平、实验室检查结果、心电图(ECG)、患者管理和治疗结果等数据。病例被分为急性和慢性中毒:结果:在1965 份病历中,有 70 名患者的 CBX 水平超过了治疗范围(发病率:3.6%)。慢性 CBX 中毒病例(55.7%)占大多数,其中胃肠道症状最为常见。大多数患者表现为单独的 CBX 过量(88.6%),而混合过量(11.4%)则较少见。根据 CBX 水平对患者进行了分类:44 例轻度中毒(>51 μmol/L),26 例中度中毒(>85 μmol/L)。在轻度组中,15 名患者出现急性毒性,而在中度组中,16 名患者出现急性毒性。四名混合过量和神志不清的患者需要插管和机械通气。三名患者服用了活性炭(AC),另有三名患者服用了多剂量的活性炭以减少药物吸收。大多数患者(65.7%)需要入院治疗,这凸显了 CBX 药物中毒的严重性。这 70 名患者中没有死亡病例:本研究强调了系统评估和管理CBX毒性的重要性,同时考虑到了其不同的临床表现和血清CBX水平的变化:Hazra D, Ellouze NF, Abri SA.急诊科卡马西平中毒的发病率和结果:单中心回顾性研究。Indian J Crit Care Med 2024;28(9):866-870.
{"title":"Prevalence and Outcomes of Carbamazepine Toxicity in the Emergency Department: A Single-center Retrospective Study.","authors":"Darpanarayan Hazra, Nejah F Ellouze, Suad A Abri","doi":"10.5005/jp-journals-10071-24795","DOIUrl":"10.5005/jp-journals-10071-24795","url":null,"abstract":"<p><strong>Background: </strong>Carbamazepine (CBX) is widely used for various medical conditions, but its associated toxicity poses significant clinical concerns. This study aims to provide insights into the clinical presentations, management strategies, and outcomes of CBX toxicity cases in an emergency department (ED) setting.</p><p><strong>Methodology: </strong>This was a 10-year retrospective cohort chart review study, including all patients with elevated CBX levels. Data on clinical features, CBX levels, laboratory findings, electrocardiograms (ECGs), patient management, and outcomes were analyzed. Cases were categorized as acute or chronic toxicity.</p><p><strong>Results: </strong>Out of the 1,965 medical charts reviewed, we included 70 patients with CBX levels above the therapeutic range (prevalence: 3.6%). Chronic CBX toxicity cases (55.7%) were predominant, with gastrointestinal (GI) symptoms being the most common. Most patients presented with isolated CBX overdoses (88.6%), while mixed overdoses (11.4%) were less frequent. Patients were categorized based on CBX levels: 44 had mild toxicity (>51 μmol/L), and 26 had moderate toxicity (>85 μmol/L). Within the mild group, 15 patients experienced acute toxicity, compared to 16 patients in the moderate group. Four patients who had mixed overdoses and low sensorium required intubation and mechanical ventilation. Three patients received activated charcoal (AC), and another 3 patients received multiple doses of AC to reduce drug absorption. The majority of patients (65.7%) required hospital admission, underscoring the seriousness of CBX toxicity. There were no fatalities among these 70 patients.</p><p><strong>Conclusion: </strong>This study emphasizes the importance of a systematic approach to assessing and managing CBX toxicity, considering its diverse clinical presentations and variations in serum CBX levels.</p><p><strong>How to cite this article: </strong>Hazra D, Ellouze NF, Abri SA. Prevalence and Outcomes of Carbamazepine Toxicity in the Emergency Department: A Single-center Retrospective Study. Indian J Crit Care Med 2024;28(9):866-870.</p>","PeriodicalId":47664,"journal":{"name":"Indian Journal of Critical Care Medicine","volume":"28 9","pages":"866-870"},"PeriodicalIF":1.5,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11443275/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142366989","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Indian Journal of Critical Care Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1